Ozempic maker struggles as it loses ground to rivals in weight-loss market
Novo Nordisk cuts sales and profit forecasts as it continues to lose ground to Mounjaro firm Eli Lilly The maker of Ozempic and Wegovy has cut its sales and profit forecasts as it continues to fall behind in the competitive market for obesity and diabetes treatments. Novo Nordisk’s chief (…)
Site référencé:
The Guardian (Asia Pacific)
2847.jpg?width=140&quality=85&auto=format&fit=max&s=6294b6e1775d2a17950bf012b978e85a, 2847.jpg?width=460&quality=85&auto=format&fit=max&s=8d07e42f8ba690d3879851340f11f6eb, 2847.jpg?width=700&quality=85&auto=format&fit=max&s=0e2d0a82e6ad2e53e2b962b0aa290d0a
The Guardian (Asia Pacific)
Tom’s Crossing by Mark Z Danielewski – House of Leaves author returns with a 1200-page western
4/11/2025
Apple Watch SE 3 review : the bargain smartwatch for iPhone
4/11/2025
‘The Irish landscape whispers tales of the past’ : a trip beyond the blarney in far-flung Donegal
4/11/2025
London Ulez auto pay blunders have triggered £11,445 in fines
4/11/2025
Ho ho … no tat ! 15 sustainable Christmas gifts for young children
3/11/2025
Rosalía : Lux review – a demanding, distinctive clash of classical and chaos that couldn’t be by anyone else
3/11/2025